论文部分内容阅读
目的评价本院治疗Ig A肾病的用药合理性,为其合理使用提供建议。方法采用用药频度分析性法对本院2013~2015年3年期间的共242张临床诊断为Ig A肾病的处方进行用药合理性分析。结果共收集本院242张处方,其中包括2013年60张,2014年55张,2015年127张。中成药用药频度(DDDs)正逐年上升,糖皮质激素用药频度有所下降;醋酸泼尼松片3年来用药频度均名列前三,降压药ACEI类和ARB类用药频度也位居前十。糖皮激素类药物、硝苯地平控释片和一些PPI类药物的DUI值大于1。结论本院以糖皮激素和干预RAS通路的降压药为Ig A肾病的主要治疗手段;中成药的使用呈增长趋势,其应用均合理;奥美拉唑肠溶片和硝苯地平控释片用药频度过高,存在滥用现象,建议按说明书和相关疾病指南调整用药方案,其余药品的使用均合理。
Objective To evaluate the rationality of treatment for IgA nephropathy in our hospital and provide suggestions for its rational use. Methods A total of 242 prescriptions for IgA nephropathy clinically diagnosed during the three-year period from 2013 to 2015 in our hospital were analyzed by medication frequency analysis method. Results A total of 242 prescriptions were collected in this hospital, including 60 in 2013, 55 in 2014 and 127 in 2015. Chinese medicine drug frequency (DDDs) is increasing year by year, the frequency of glucocorticoid medication declined; prednisone tablets three years frequency of medication ranked top three, antihypertensive agents ACEI and ARB medication frequency Top ten. DUI values for glucocorticoid drugs, nifedipine GITS, and some PPIs are greater than one. Conclusions In our hospital, the antihypertensive drugs with glucocorticoid and interventional RAS pathway are the main therapeutic approaches for IgA nephropathy. The use of proprietary Chinese medicines shows an increasing trend and its application is reasonable. The controlled release of omeprazole enteric-coated tablets and nifedipine The frequency of medication is too high, there is abuse phenomenon, it is recommended to adjust the medication plan according to the manual and the relevant disease guidelines, the use of the remaining drugs are reasonable.